CLYM

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 11 K-162 K-33 K-72 K-25 K -292 K Gross profit 11 K-162 K-33 K-72 K-25 K -292 K Operating expenses 23.02 M10.68 M14.89 M19.3 M15.21 M 60.08 M Selling/general/admin expenses 5.69 M4.1 M5.82 M5.56 M5.84 M 21.32 M Research & development 17.33 M6.58 M9.07 M13.74 M9.37 M 38.76 M Operating income -23.02 M-10.68 M-14.89 M-19.3 M-15.21 M -60.08 M Non-Operating Income, Total 2.24 M2.01 M2 M1.75 M1.49 M 7.26 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 02.01 M2 M-741 K1.49 M 4.76 M Unusual income/expense 2.24 M——2.5 M— — Pretax income -20.78 M-8.67 M-12.89 M-17.54 M-13.72 M -52.82 M Equity in earnings ————— — Taxes 0——-293 K— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -20.78 M-8.67 M-12.89 M-17.52 M-13.72 M -52.79 M Discontinued operations ————— — Net income -20.78 M-8.67 M-12.89 M-17.52 M-13.72 M -52.79 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -20.78 M-8.67 M-12.89 M-17.52 M-13.72 M -52.79 M Basic earnings per share (Basic EPS) -0.31-0.13-0.19-0.25-0.2 -0.77 Diluted earnings per share (Diluted EPS) -0.31-0.13-0.19-0.25-0.2 -0.77 Average basic shares outstanding 67.46 M67.59 M68 M66.69 M47.77 M — Diluted shares outstanding 67.46 M67.59 M68 M66.69 M47.77 M — EBITDA -23.68 M-10.8 M-14.9 M-19.34 M-15.2 M -60.23 M EBIT -23.01 M-10.84 M-14.93 M-19.37 M-15.24 M -60.37 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -669 K38 K29 K30 K38 K 135 K